View on Pubmed.gov 39114917 | View on doi.org 10.1161/ATVBAHA...
Role of Antibodies and Their Specificities in Atherosclerotic Cardiovascular Disease.
- Department of Laboratory Medicine, Medical University of Vienna, Austria.
Abstract
Atherosclerosis is a lipid-driven chronic inflammatory disease that is modulated by innate and adaptive immunity including humoral immunity. Importantly, antibody alterations achieved by genetic means or active and passive immunization strategies in preclinical studies can improve or aggravate atherosclerosis. Additionally, a wide range of epidemiological data demonstrate not only an association between the total levels of different antibody isotypes but also levels of antibodies targeting specific antigens with atherosclerotic cardiovascular disease. Here, we discuss the potential role of atherogenic dyslipidemia on the antibody repertoire and review potential antibody-mediated effector mechanisms involved in atherosclerosis development highlighting the major atherosclerosis-associated antigens that trigger antibody responses.
References
Cited by 2 citations (total)
Journal Article Review
Clinical associations and potential cellular mechanisms linking G6PD deficiency and atherosclerotic cardiovascular disease.
Electronic publication date April 28, 2025
Patrick H Andrews [...] Coleen A McNamara et al.
Glucose 6-phosphate dehydrogenase deficiency (G6PD-d) is the most common enzymopathy in the world, occurring in 5-8% of the global population...
Journal Article Review
Orticumab: the potential to harness oxidized LDL to reduce coronary inflammation with plaque-targeted therapy.
Electronic publication date July 3, 2025
Christopher J Farina [...] Jan Nilsson et al.
PURPOSE OF REVIEW
Myocardial infarction survivors are at a high risk of a recurrent event despite receiving guideline preventive therapy. There...
Conflict of interest statement
None.
MeSH
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •